HES
49
2
SWK
53
4
PX
56
3
URBN
67
3
FITB
36
3
FOXA
67
5
EOG
28
2
TMO
52
8
CNP
59
17
PFE
37
4
CMCSA
49
3
F
38
4
EXPE
83
8
FTI
61
5
AAP
26
5
HAS
29
3
NWL
48
4
NTAP
58
3
SO
48
6
TGT
35
4
HES
49
2
SWK
53
4
PX
56
3
URBN
67
3
FITB
36
3
FOXA
67
5
EOG
28
2
TMO
52
8
CNP
59
17
PFE
37
4
CMCSA
49
3
F
38
4
EXPE
83
8
FTI
61
5
AAP
26
5
HAS
29
3
NWL
48
4
NTAP
58
3
SO
48
6
TGT
35
4
Financhill
Back

Alexandria Real Estate Equities Vs. Novo Nordisk AS Industry Stock Comparison

Sell
14

ARE
Alexandria Real Estate Equities

Last Price:
$99.23
Seasonality Move:
-0.04%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
14
Alexandria Real Estate Equities (ARE) is a Sell

Is Alexandria Real Estate Equities a Buy, Sell or Hold?

  • The current Alexandria Real Estate Equities [ARE] share price is $99.17. The Score for ARE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • ARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ARE Stock Price Chart

What is Alexandria Real Estate Equities's stock price today?

  • The Alexandria Real Estate Equities share price today is $99.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARE is experiencing slight selling pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.09 Sell
Relative Strength Index (14 RSI): 34.7 Sell
Chaikin Money Flow: -611556 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.24 - 109.02) Sell
Bollinger Bands (100): (107.39 - 120.43) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

ARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.85 Sell
20-day SMA: 105.14 Sell
50-day SMA: 109.96 Sell
200-day SMA: 117.24 Sell
8-day EMA: 100.69 Sell
20-day EMA: 103.83 Sell
50-day EMA: 108.46 Sell
200-day EMA: 115.29 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Alexandria Real Estate Equities Earnings Growth & ARE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.84 per share, and a decrease next year of $0.49 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Alexandria Real Estate Equities Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):